Data as of Mar 07
| +0.51 / +4.51%|
The 4 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 14.00. The median estimate represents a +35.25% increase from the last price of 11.83.
The current consensus among 4 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.